The chairman of Maiwei Biology (688062.SH) proposed to repurchase company shares worth 25 million to 50 million yuan.

Financial and Economic Information APP reports that Maiwei Bio (688062.SH) has announced that on June 4, 2025, the company received a letter submitted by Mr. Liu Datao, the Chairman and General Manager of the company, proposing the repurchase of company shares by Maiwei (Shanghai) Biotechnology Co., Ltd. The total amount of funds for this repurchase shall not be less than RMB 25 million (inclusive), and shall not exceed RMB 50 million (inclusive). The source of funds for repurchasing shares: own funds and/or special stock repurchase loans. The repurchase price per share shall not exceed RMB 35.00 (inclusive).